Loading...
Cancer immunotherapy using a bi-specific NK receptor- fusion protein that engages both T cells and tumor cells
T cell immunotherapy is a promising strategy to treat cancer. The aim of this study was to investigate a new approach to deliver selective T cell activation against tumor cells. We have developed a bi-specific fusion protein that recognizes tumor cells through an NK activating receptor NKG2D and sti...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095211/ https://ncbi.nlm.nih.gov/pubmed/21282338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-3200 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|